Sandborn W.J et al. Efficacy and Safety of Extended Induction with Tofacitinib for The Treatment of Ulcerative Colitis. Clin Gastroenterol Hepatol.

Reich K et al. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate to severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial. Lancet.

M.C. Dubinsky et al., Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program, Inflammatory Bowel Diseases.

Jean-Frederic Colombel et al. Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 

Bonovas S. et al., Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD technical review based on the GRADE methodology, Digestive and Liver Disease.